Illustratively, a recent cerebrospinal fluid (CSF) study reported that levels of total and oligomeric α-synuclein and TNF-α discriminate L2NMC from L2PD and iPD, and controls53, thus proposing these candidates as risk biomarkers in prodromal PD stages. This evidence concerns the gene TNF and Parkinson disease.